PODCAST with Prof. Arnon Kater about fixed-duration ibrutinib and venetoclax for first-line treatment of CLL
Ariez Publishing
PODCAST with Prof. Arnon Kater about fixed-duration ibrutinib and venetoclax for first-line treatment of CLL
00:00 / 05:54